DALLAS, Dec. 9 /PRNewswire-FirstCall/ -- Keith Houser, CEO of BioTech Medics, Inc., (OTC Pink Sheets: BTMD) issued a statement chronicling the accomplishments during the first year anniversary of the reverse/merger between Corbel Holdings, Inc., and HaloLaser BioTherapy, LLC. "During the past year BTMD has accomplished much," said Mr. Houser. "We closed on the reverse/merger on time. The previous directors and officers were replaced immediately. Under new management and a new board of directors we hired a CPA firm to start an audit of the merged companies. The auditors have completed IRS filings through 2004, but not completed the audit. We pledged 'no reverse stock split' and we have kept our word. "BioTech Medics has acquired over $2.5 million in assets this year (with cash and treasury stock) and has a steady revenue income in the management agreement with Charles R. Crane MD & Associates in forming our first Pain Management & Wellness Center in Dallas, Texas. Additionally BTMD acquired 5 US Letters of Patent from FHJ and have started marketing the proprietary SHBAN Cleaning & Disinfecting Solution. BTMD entered into a distributorship agreement with Laser Neurotherapy Development Labs and have sold the NeuroLase Medical Laser device to clinics in the USA. We negotiated turnkey financing for the laser acquisitions through First Financial Leasing & Financing. Mr. Houser stated: "In 2004 Corbel had under $500,000 in Real Estate Assets. Since the reverse/merger BTMD has had a 400% increase in non-real estate Assets. BTMD estimates to close 2005 with combined Gross Revenues around $ 1 million. The 2005 BTMD revenues are projected to be nearly 20 times higher than 2004. "BTMD plans on closing on more new Pain Management & Wellness Centers in 2006, as well as acquiring a permanent office building in Dallas, Texas. We pledge to strive to add more assets and increased revenue for the company to bring more value to the stock and its more than 5,800 shareholders in 22 countries. This in turn should provide BTMD the opportunity to become a reporting company and the possibility to move up to a major exchange." For More Information Contact BioTech Medics at 972-274-5533 or on the Internet at: http://www.biotechmedics.com/ Safe Harbor for Forward-Looking Statements This press contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). In Particular, when used in the preceding discussion, the words "plan," "expect," or "intend to," and similar conditional expressions are intended to identify forward- looking statements within the meaning of the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed. Such risks and uncertainties include, but are not limited to, the ability of the company to have adequate financing, market conditions, the general acceptance of the Company's products and technologies, competitive factors, timing, and other risks. CONTACT: BioTech Medics, Inc., +1-972-274-5533 DATASOURCE: BioTech Medics, Inc. CONTACT: BioTech Medics, Inc., +1-972-274-5533 Web site: http://www.biotechmedics.com/

Copyright